Browse the corpus

REFERENCES Adler-Shohet F, Waskin H, and Lieberman JM, "Amphotericin B Lipid Complex for Neonatal Invasive Candidiasis," Arch Dis Child Fetal Neonatal Ed , 2001, 84(2):F131-3. [PubMed 11207232 ] Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed, Philadelphia, PA: American College of Physicians, 2007, 97, 169. Centers for Disease Control and Prevention (CDC), "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America," MMWR Recomm Rep , 2009a, 58(RR-4):1-207. [PubMed 19357635 ] Centers for Disease Control and Prevention (CDC), "Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children," MMWR Recomm Rep , 2009, 58(RR-11):1-166. Available at file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf [PubMed 19730409 ] Cetin H, Yalaz M, Akisu M, et al, "The Efficacy of Two Different Lipid-Based Amphotericin B in Neonatal Candida Septicemia," Pediatr Int , 2005, 47(6):676-80. [PubMed 16354223 ] Chapman SW, Dismukes WE, Proia LA, et al, "Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2008, 46(12):1801-12. [PubMed 18462107 ] Galgiani JN, Ampel NM, Blair JE, et al, "Coccidioidomycosis," Clin Infect Dis , 2005, 41(9):1217-23. [PubMed 16206093 ] Pappas PG, Kauffman CA, Andes D, et al, "Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2009, 48(5):503-35. [PubMed 19191635 ] Perfect JR, Dismukes WE, Dromer F, et al, "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2010, 50(3):291-322. [PubMed 20047480 ] Sacks GS and Cleary JD, “Nutritional Impact of Lipid-Associated Amphotericin B Formulations,” Ann Pharmacother , 1997, 31(1):121-2. [PubMed 8997484 ] Tunkel AR, Glaser CA, Bloch KC, et al, “The Management of Encephalitis: Clinical Practice Guidelines from the Infectious Diseases Society of America,” Clin Infect Dis , 2008, 47(3):303-27. [PubMed 18582201 ]

Sacks GS and Cleary JD, “Nutritional Impact of Lipid-Associated Amphotericin B Formulations,” Ann Pharmacother , 1997, 31(1):121-2. [PubMed 8997484 ] Tunkel AR, Glaser CA, Bloch KC, et al, “The Management of Encephalitis: Clinical Practice Guidelines from the Infectious Diseases Society of America,” Clin Infect Dis , 2008, 47(3):303-27. [PubMed 18582201 ] Walsh TJ, Anaissie EJ, Denning DW, et al, “Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America,” Clin Infect Dis , 2008, 46(3):327-60. [PubMed 18177225 ] Wheat LJ, Freifeld AG, Kleiman MB, et al, "Clinical Practice Guidelines for the Management of Patients With Histoplasmosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(7):807-25. [PubMed 17806045 ] Würthwein G, Groll AH, Hempel G, et al, "Population Pharmacokinetics of Amphotericin B Lipid Complex in Neonates," Antimicrob Agents Chemother , 2005, 49(12):5092-8. [PubMed 16304177 ] Topic 12660 Version 35.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [1103-41.222.196.37-062E1C4994-S473950.14]